<?xml version="1.0" encoding="UTF-8"?>
<p id="par0055">These are the findings that precede the clinical trial led by Didier Raoult, led by Gautret and published on 
 <bold>20th March</bold>, which found that, on the sixth day of the start of the study, only 12.5% of the patients in the control group had become negative compared to 57.1% of the patients who received 200 daily mg of hydroxychloroquine sulphate for 10 days, and 100% of those who received the combination of hydroxychloroquine and azithromycin, the latter at doses of 500 mg on day 1, followed by 250 mg/day during the subsequent 4 days.
 <xref rid="bib0180" ref-type="bibr">
  <sup>13</sup>
 </xref>
</p>
